Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.15B |
| 2 |
Amazon
AMZN
|
+$618M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$554M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$437M |
| 5 |
Apple
AAPL
|
+$333M |
Top Sells
| 1 |
Visa
V
|
+$2.38B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.59B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$993M |
| 5 |
DuPont de Nemours
DD
|
+$761M |
Sector Composition
| 1 | Technology | 20.31% |
| 2 | Financials | 12.52% |
| 3 | Consumer Discretionary | 10.54% |
| 4 | Communication Services | 10.36% |
| 5 | Healthcare | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2201
MSC Industrial Direct
MSM
$5.09B
| $610K | ﹤0.01% |
7,231
-906
| -11% | -$76.4K |
|
2202
Littelfuse
LFUS
$6.54B
| $609K | ﹤0.01% |
2,390
-314
| -12% | -$80K |
|
2203
abrdn Physical Gold Shares ETF
SGOL
$5.8B
| $606K | ﹤0.01% |
33,130
+11,038
| +50% | +$202K |
|
2204
Axogen
AXGN
$755M
| $605K | ﹤0.01% |
33,794
-4,941
| -13% | -$88.5K |
|
|
MODN
2205
DELISTED
MODEL N, INC.
MODN
| $604K | ﹤0.01% |
16,931
-5,141
| -23% | -$183K |
|
2206
Y-mAbs Therapeutics
YMAB
$390M
| $602K | ﹤0.01% |
12,144
-36,411
| -75% | -$1.8M |
|
|
ATSG
2207
DELISTED
Air Transport Services Group, Inc.
ATSG
| $601K | ﹤0.01% |
19,188
-7,747
| -29% | -$243K |
|
|
SALM
2208
DELISTED
Salem Media Group, Inc. Class A Common Stock
SALM
| $598K | ﹤0.01% |
+575,000
| New | +$598K |
|
2209
Cushman & Wakefield
CWK
$3.85B
| $590K | ﹤0.01% |
39,697
-61,500
| -61% | -$914K |
|
|
SLCT
2210
DELISTED
Select Bancorp, Inc.
SLCT
| $590K | ﹤0.01% |
62,336
-2,149
| -3% | -$20.3K |
|
2211
CytomX Therapeutics
CTMX
$330M
| $589K | ﹤0.01% |
90,014
+60,474
| +205% | +$396K |
|
2212
Huron Consulting
HURN
$2.44B
| $589K | ﹤0.01% |
9,989
-2,708
| -21% | -$160K |
|
2213
Rush Enterprises Class B
RUSHB
$4.5B
| $587K | ﹤0.01% |
23,252
+2,365
| +11% | +$59.7K |
|
|
UFS
2214
DELISTED
DOMTAR CORPORATION (New)
UFS
| $584K | ﹤0.01% |
18,466
-7,159
| -28% | -$226K |
|
2215
Celsius Holdings
CELH
$14.9B
| $583K | ﹤0.01% |
34,731
-12,567
| -27% | -$211K |
|
|
QVCGA
2216
QVC Group, Inc. Series A Common Stock
QVCGA
$92M
| $581K | ﹤0.01% |
1,058
-51
| -5% | -$28K |
|
2217
Bruker
BRKR
$4.69B
| $580K | ﹤0.01% |
10,724
+211
| +2% | +$11.4K |
|
2218
Curtiss-Wright
CW
$19.2B
| $579K | ﹤0.01% |
4,972
-1,111
| -18% | -$129K |
|
|
TECX
2219
Tectonic Therapeutic, Inc. Common Stock
TECX
$332M
| $579K | ﹤0.01% |
3,460
+1,984
| +134% | +$332K |
|
|
DRNA
2220
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $579K | ﹤0.01% |
26,255
-7,665
| -23% | -$169K |
|
2221
Seres Therapeutics
MCRB
$139M
| $578K | ﹤0.01% |
1,182
-339
| -22% | -$166K |
|
|
MBT
2222
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $578K | ﹤0.01% |
64,601
-25,046
| -28% | -$224K |
|
|
CRON
2223
Cronos Group
CRON
$969M
| $577K | ﹤0.01% |
83,028
-122,024
| -60% | -$848K |
|
2224
Kadant
KAI
$3.69B
| $577K | ﹤0.01% |
4,091
-1,677
| -29% | -$237K |
|
2225
Greenlight Captial
GLRE
$426M
| $576K | ﹤0.01% |
78,769
+36,472
| +86% | +$267K |
|